Asset One logo

Asset One

Asia, Seoul-t'ukpyolsi, South Korea, Seoul

Description

Asset One is a full-licensed, comprehensive asset management company based in Seoul, Korea.

Investor Profile

Asset One has made 1 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series C (100%)

Country Focus

  • South Korea (100%)

Industry Focus

  • Artificial Intelligence (Ai)
  • Biotechnology
  • Health Care
  • Machine Learning
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Asset One frequently co-invest with?

DSC Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
WONIK Investment Partners
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
LB Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
KB
Europe, Budapest, Hungary, Budapest
Co-Investments: 1
SP
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Kakao Ventures
Asia, Kyonggi-do, South Korea, Seongnam
Co-Investments: 1
InterVest Co.
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Atinum Partners
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Daishin Securities
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1

What are some of recent deals done by Asset One?

Standigm

Seoul, Seoul-t'ukpyolsi, South Korea

Standigm is an AI-driven workflow drug discovery company that aims to improve the success rates and efficiency of new drug development.

Artificial Intelligence (AI)BiotechnologyHealth CareMachine LearningPharmaceutical
Series CMar 5, 2021
Amount Raised: $36,410,000